- Met and its ligand HGF are associated with clinical outcome in breast cancer
Cynthia Veenstra et al, 2016, Oncotarget CrossRef - Macrophage HIF‐2α regulates tumor‐suppressive Spint1 in the tumor microenvironment
Rosa M. Susen et al, 2019, Molecular Carcinogenesis CrossRef - Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis
Chao-yuan Huang et al, 2017, Oncotarget CrossRef - Targeting the effect of sofosbuvir on selective oncogenes expression level of hepatocellular carcinoma Ras/Raf/MEK/ERK pathway in Huh7 cell line
Muhammad Atif et al, 2022, Saudi Journal of Biological Sciences CrossRef - Comprehensive Analysis of the Expression and Prognostic Value of SPINT1/2 in Breast Carcinoma
Qiulin Wu et al, 2021, Frontiers in Endocrinology CrossRef - TargetingHGFwith Antibodies as an Anti‐Cancer Therapeutic Strategy
Dinuka M. De Silva et al, 2018, Extracellular Targeting of Cell Signaling in Cancer CrossRef - Hepatocyte growth factor pathway expression in breast cancer by race and subtype
Gieira S. Jones et al, 2021, Breast Cancer Research CrossRef - Bioinformatics analysis identifies potential chemoresistance‑associated genes across multiple types of cancer
Jingsheng Yuan et al, 2019, Oncology Letters CrossRef - Hepatocyte growth factor/MET in cancer progression and biomarker discovery
Kunio Matsumoto et al, 2017, Cancer Science CrossRef - MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer
Yongbing Chen et al, 2016, Oncotarget CrossRef - High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Si-Qi Qiu et al, 2020, Breast Cancer Research CrossRef